72.19.Z - Other research and experimental development on natural sciences and engineering
20.42.Z - Manufacture of perfumes and toilet preparations
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.19.Z - Agents involved in the sale of a variety of goods
46.45.Z - Wholesale of perfume and cosmetics
46.46.Z - Wholesale of pharmaceutical goods
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
73.20.Z - Market research and public opinion polling
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 348,6 | |||
Gross profit (loss) | 0,1 | -1 | -0 | 99,2 |
EBITDA | 0,1 | -0,9 | 0 | 100,2 |
Short time liabilities | 0,2 | 1,2 | 1,9 | 52,6 |
Other operating costs | 560 | |||
Equity capital | 0,1 | -0,8 | -0,9 | -0,9 |
Operating profit (EBIT) | 0,1 | -0,9 | -0 | 99,5 |
Assets | 4,5 | 3 | 2,9 | -5 |
Net profit (loss) | 0 | -1 | -0 | 99,2 |
Cash | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 4,4 | 3,9 | 3,7 | -3,7 |
Net income from sale | 6,8 | 5,5 | 0,5 | -90,4 |
Working assets | 3,9 | 2,6 | 2,7 | 2,9 |
Other income costs | 6975 | |||
Depreciation | 0 | 0 | 0 | -81,2 |
% | % | % | p.p. | |
Profitability of capital | 32,3 | 117,4 | 0,9 | -116,5 |
Equity capital to total assets | 3,3 | -27,9 | -29,6 | -1,7 |
Gross profit margin | 0,8 | -18,2 | -1,5 | 16,7 |
EBITDA Margin | 1,3 | -16,5 | 0,3 | 16,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 11 | 81 | 1296 | 1215 |
Current financial liquidity indicator | 1.083800196647644 | 0.7898420095443726 | 0.7178727984428406 | -0,1 |
Net dept to EBITDA | 8.204253196716309 | -1.1720579862594604 | 491.77685546875 | 493 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane